Quality of Life Outcomes for Patients Who Underwent Conventional Resection and Liver Transplantation for Locally Advanced Hepatoblastoma
With Dr. Dr. Sophia Schermerhorn · StayCurrentMD
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
BOB Ped Surg 2023 - Andrew Fleming, AAP - Presentation
Published Feb 2023
Video
Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience
1 min · Published Jan 2026
Video
Aggressive Pursuit of No Evidence of Disease Status in Hepatoblastoma Improves Survival
Published Jun 2023
Video
Hepatoblastoma with Dr. Greg Tiao
CCHMC Pediatric Surgery · Published Mar 2022
Video
Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and Hepatoblastoma
1 min · Published Jan 2026
Video
Hepatoblastoma: Update Course 2014
24 min · Published Nov 2018
Only a few other public items share this expert — go deeper there →
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
What the experts said
Survival for hepatoblastoma continues to improve.
Long-term quality of life is becoming a more important outcome as hepatoblastoma survival improves.
This is a single institution cross-sectional study using validated pediatric quality of life surveys to evaluate long-term survivors of hepatoblastoma.
Overall quality of life outcomes were similar between liver transplant and resection groups for hepatoblastoma.
There was no significant difference in emotional, social, physical, or school functioning outcomes between transplant and resection groups.
Patients who underwent resection had lower overall procedure anxiety scores than transplant patients.
The finding of lower procedural anxiety in resection patients was mirrored in the parents' surveys.
Long-term quality of life outcomes appear comparable between patients who undergo resection and liver transplantation for hepatoblastoma.
Surgical strategy for hepatoblastoma can be focused on oncologic control given comparable quality of life outcomes.